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Purpose. Port-site metastasis has been a concern with the common use of laparoscopy in urologic oncology. We conducted this
study to provide a review of port-site metastases reported after the laparoscopy in managing urologic malignancies, possible
contributing factors and preventative measures. Materials and Methods. An electronic search of MEDLINE using the combined
MESHkeywords“port-sitemetastasis”and“Urology”.Results.51articlesaddressingport-sitemetastasisafterlaparoscopicsurgery
for urolo¬gical malignancy were identiﬁed. Conclusion. Port-site metastasis after laparoscopic surgery for urolo¬gical malignancy
is rare. The incidence is comparable to the rate for surgical wound metastases.
1.Introduction
In recent years, with the widespread use of laparoscopy to
treat an ever-increasing number of urologic malignancies,
questions have been raised about the oncologic safety of
this surgical approach [1]. Currently, a large number of
specialized centres around the world perform laparoscopy
f o ru r o l o g i cc a n c e r[ 2, 3]. Nevertheless, local recurrence and
port-site metastasis remain a concern [4].
Port-site metastases, though rare, have been extensively
documented for other gynaecological and GI malignancies.
When they occur, they often do so in the presence of
advanced disease, but it is not uncommon for them to
occur in isolation [5, 6]. Concern has been expressed that
laparoscopic surgery might adversely aﬀect the long-term
outcomes by increasing the risk of port-site and peritoneal
seeding.
The ﬁrst known report of a port-site metastasis was
by Dobronte and associates [7] in 1978. The authors
reported implantation of malignant ovarian cystic adenoma
in penetration sites of the pneumo-needle and trocar. Some
speciﬁc procedures and tumors have been associated with
a higher incidence of portsite metastasis or tumor seeding;
however, the precise incidence of port-site metastasis and
its aetiology and pathogenesis have not been well deﬁned in
urologic laparoscopy [8].
Port-site metastases is a multifactorial phenomenon with
anas-yetundeterminedincidence.Etiologicalfactorsinclude
natural malignant disease behavior [9], host immune status
[9], local wound factors [9], laparoscopy-related factors such
as aerosolization of tumor cells (the use of gas, type of
gas, insuﬄation and desuﬄation, and pneumoperitoneum)
[9], and suﬃcient technical experience of the surgeons and
operating team [9] (adequate laparoscopic equipment, skill,
minimal handling of the tumor, surgical manipulation and
wound contamination during instruments change, organ
morcellation, and specimen removal) [9].
2.MaterialsandMethods
An electronic search of MEDLINE of the published literature
up to 2010 was carried out using the combined MESH key
words “port-site metastasis” and “Urology.”
Duplicate references, as well as repeated references to
the same data sets, were removed. The articles and case
reports directly addressing port-site metastasis after laparo-
scopic surgery for urological malignancy were reviewed.2 Advances in Urology
Articles were selected and categorized by topic into inci-
dence, aetiology, pathophysiology, and possible preventative
measures.
3. Results
Table 1 showed the case reports found on MEDLINE search
of the published literature up to 2010 recovered 51 for the
MESH words “port-site metastasis” and “Urology.”
Etiological factor has been categorised in three main
categories: tumour related, wound related, and surgical
technique related. Surgical technique related factors have
been categorised in two main categories: manipulation is the
principal factor acting in tumour dissemination. Extraction
of the surgical specimen is determined by the surgeon. The
possible preventive measure has been categorised in two
main categories: active measures and measures for reducing
the risk of laparoscopic port-site metastasis in urological
surgery.
4. Discussion
Laparoscopic surgery is rapidly gaining widespread accep-
tance among urologists, including extensive application in
malignant conditions [9]. The incidence of tumour seeding
in general laparoscopic surgery ranges from 0.8% to 21%
(8, 9). However, most authors report an incidence of 0.5%,
comparabletotherateforsurgicalwoundmetastases(0.8%–
1.6%) in conventional open methods [9–11]. In recent years,
several reports of port-site metastasis and tumor seeding
have been published. Tsivian and Sidi [9]a l o n er e p o r t e d
nine cases of port-site metastases after urologic laparoscopy,
and Rassweiler and colleagues [10] published eight local
recurrences observed in 1098 laparoscopic procedures for
urologicmalignancies.Recently,inaninternationalsurveyof
19 urologic laparoscopic centres performing a total of 18,750
laparoscopic procedures for urologic malignancies, tumour
seeding was reported in 13 cases (0.1%) [8].
Various theories tried to explain metastasis development
at laparoscopic port site [12]. Factors can be divided into
three categories: tumor related, wound related, and surgical
technique related [4].
Tumor-related factors [8–10]: biological aggressiveness
of the tumor, represented by grade and stage, could play
a decisive role in possible tumor seeding determination,
explaining why grade 2 and 3 transitional cell carcinomas
represent the majority of port-site metastases in urological
procedures [8–10].
Wound-related factors [11–17]: local and systemic
immune response to the pneumoperitoneum has been
suggested. Its physiopathological mechanism has yet to be
completely deﬁned. There is a tendency towards systemic
preservation of the immune system and towards immune
depression of the peritoneum during laparoscopic insuf-
ﬂation demonstrated by macrophage function alteration
[11–17].
Surgical technique-related factors [9, 18–30]: manipula-
tion is the principal factor acting in tumor dissemination.
Extraction of the surgical specimen is determined by the
surgeons [9, 18–30].
However, it is logical to assume that morcellation of
the specimen increases tumor seeding [5, 6, 15]. The direct
dissemination of tumor cells from contaminated material or
from extraction with an unclosed bag is well documented
[5, 6, 15] .T h eo b s e r v a n c eo fal a r g en u m b e ro ft u m o rc e l l s
at excessively manipulated ports supports this hypothesis as
well as observance of greater number of malignant cells at
port sites used by the surgeon compared with those used by
assistants [5, 6, 15].
Theproblemisinﬂuencedtosomeextentbysurgeonand
operatingteamexperience[9,31–37],and,therefore,itcould
be partially prevented [9, 31–37].
Port-site recurrence of tumour is a particular, and
increasingly recognized [9, 31–37], drawback. certain mea-
sures have been suggested to prevent urologic port-site
metastasis [9, 31–37], including (1) suﬃcient technical
preparation, (2) avoidance of laparoscopic surgery if ascites
ispresent [9, 31–37], (3) trocar ﬁxation with avoidance
of gas leakage along the trocar, (4) avoidance of tumor-
boundary violation [9, 31–37], (5) cautious consideration of
morcellation, (6) use of an impermeable bag if morcellation
is done [9, 31–37], (7) use of a bag for intact specimen
removal, (8) drainage placement if needed before abdominal
deﬂation [9, 31–37], (9) povidone-iodine irrigation of the
laparoscopic instruments, trocar, and port-site wounds [9,
31–37], and (10) suturing 10mm trocar wounds [9, 31–
37]. Povidone-iodine irrigation has been questioned, and
peritoneal irritation secondary to this agent must not be
underestimated [9, 31–37]. Regarding suggestion 10, Burns
and coworkers [21]d e m o n s t r a t e do na na n i m a lm o d e l
that portsite tumor implantation was signiﬁcantly increased
(P<0.03) when only skin was closed compared with
closure of all three layers [21]. The authors proved that
closure technique may inﬂuence the rate of port-site tumor
implantation [21]. For hand-assisted laparoscopic surgery,
Chen and collaborators [38] recommend using a watertight
bag model, not enlarging the surgical wound if there
is resistance when extracting the surgical specimen and
changing gloves before wound closure in order to avoid
contaminationwithmalignantcells[38].Port-sitemetastasis
inurologicallaparoscopicsurgeryisrare.Severalfactorshave
been associated with tumor seeding, but tumor grade and
stage appear to have the greatest importance. Nevertheless,
risk can be minimized by applying open surgery oncologic
procedural norms [9, 18–30].
5. Conclusion
Port-sitemetastasisinurologicallaparoscopicsurgeryisrare.
Multiple factors have been associated with tumour seeding,
but tumour grade and stage appear to play a major role.
Multiple methods have been described to reduce the risk of
port-site metastasis. The incidence is comparable to the rate
for surgical wound metastases.Advances in Urology 3
Table 1: The case reports found on MEDLINE.
Author Procedure Tumour type, stage, and grade Number of cases
Stolla et al., 1994 Laparoscopic pelvic lymph node dissection Bladder TCC pT3G2 1
Andersen et al.,1995 Transperitoneal laparoscopic bladder biopsy Bladder TCC T1G2 1
Bangma et al., 1995 Laporoscopic pelvic lymph node dissection PCa T3N1 1
Altieri et al., 1998 Laporoscopic pelvic lymph node dissection Bladder TCC T3G2 1
Ahmed et al., 1998 Laparoscopic nephrectomy Kidney TCC T3G3-G4 1
Otani et al., 1999 Laparoscopic nephrectomy Incidental ﬁnding of TCC, G3 within tuberculous
atrophic kidney 1
Fentie et al., 2000 Laparoscopic nephrectomy RCC T3N0G4 1
Landman and
Clayman, 2001 Laparoscopic nephrectomy RCC T1N0G2 1
Castilho et al., 2001 Laparoscopic nephrectomy RCC T1N0G2 1
Wang et al., 2002 Laparoscopic cystectomy Incidental ﬁnding of SCC in ovarian dermoid cyst 1
Chen et al., 2003 Laparoscopic nephrectomy (hand assisted) RCC T2N0M0 1
Rassweiler et al., 2003 Laparoscopic adrenalectomy Small-cell lung carcinoma adrenal metastasis 1
Laparoscopic retroperitoneal lymph node
dissection NA 1
Saraiva P et al., 2003 Laparoscopic adrenalectomy Metastatic melanoma of adrenal gland. Grade
unavailable 1
Matsui et al., 2004 Laparoscopic retroperitoneal
nephroureterectomy SCC pT3N0M0 1
Iwamura et al., 2004 Laparoscopic retroperitoneal nephrectomy RCC T1bN0M0 1
Micali et al., 2004
Laparoscopic Adrenalectomy Lung metastases pT4/G3 (3); Adrenocortical
Ca-grade and stage NA (1) 4
Laporoscopic pelvic lymph node dissection Squamous penile Ca 1
Laparoscopic retroperitoneal lymph node
dissection Nonseminomatous Germ Cell Tumor 1
Laparoscopic simple nephrectomy Incidental TCC in each instance—pT1/G2;
pT1/G3; pT2/G3; NA 4
Laparoscopic nephroureterectomy pT3/G3 3
Naderi et al., 2004 Laporoscopic nephroureterectomy Kidney TCC cT1N0M0 1
Chueh et al., 2004 Laporoscopic bilateral nephroureterectomy Grade 2 renal TCC with pelvic muscular invasion
and bladder metastasis 1
Porpiglea et al., 2004 Laparoscopic adrenalectomy Adrenal metastasis from nonsmall cell lung
carcinoma 1
El-Tabey and Shoma,
2005 Laparoscopic cystectomy (robot-assisted) Bladder TCC T3bN0M0G3 1
Kobori et al., 2005 Laparoscopic nephrectomy Papillary adenocarcinoma of pelvis. Stage and
grade unavailable 1
Dhobada et al., 2006 Laparoscopic nephrectomy RCC T2N0M0G3 1
Manabe et al., 2007 Laparoscopic nephroureterectomy Upper tract transitional cell carcinoma without
distant metastases 1
Muntener et al., 2007 Laparoscopic radical nephroureterectomy Upper tract TCC. Stage T1, high grade 1
Castillo and
Vitagliano 2008
Laparoscopic partial nephrectomy RCC T1N0M0G3 1
Laparoscopic retroperitoneal lymph node
dissection Mixed germ cell tumor T3N0M0 1
Cresswell et al., 2008 Laporoscopic retroperitoneal lymph node
dissection
Stage 1 nonseminomatous germ cell tumour.
Grade NA 1
Segawa et al., 2008 Laparoscopic nephroureterectomy and
cystectomy
Invasive bladder cancer with bone metastasis.
Grade NA 14 Advances in Urology
Table 1: Continued.
Author Procedure Tumour type, stage, and grade Number of cases
Spermon and Witjes
2008
Laparoscopic retroperitoneal lymph node
dissection
Stage IIb non seminomatous germ cell tumour
(Histology-yolk sac and teratoma elements) 1
Greco et al., 2009 Laparoscopic partial nephrectomy Renal clear cell papillary carcinoma pT1a, high
grade 1
Yasuda et al., 2009 laparoscopic nephroureterectomy Upper urinary tract carcinoma. T2N0M0 Grade 2
> 3 1
Huang et al., 2010 Laparoscopic radical cystectomy and pelvic
lymph node dissection NA 1
Pca = prostate cancer, RCC = Renal cell carcinoma, SCC cell carcinoma, NA = not available.
References
[1] G. D. Stewart and D. A. Tolley, “What are the oncological risks
of minimal access surgery for the treatment of urinary tract
cancer?” European Urology, vol. 46, no. 4, pp. 415–420, 2004.
[2] G. Vitagliano, O. Castillo, J. M. Campero, I. Pinto, and M.
D` Iaz, “Laparoscopicretroperitoneal lymph node dissection
for nonseminomatoustesticular cancer in stage T1 and T2,”
Journal of Endourology, vol. 20, supplement 1, abstract MP 21-
04, p. A235, 2006.
[3] G. Vitagliano, O. Castillo, I. Pinto, M. D` Iaz, and M. Contr-
eras, “Complications in laparoscopic transperitoneal partial
nephrectomy,” Journal of Endourology, vol. 20, supplement 1,
abstract MP 2-15, p. A10, 2006.
[4] O. A. Castillo, G. Vitagliano, M. D´ ıaz, and R. S´ anchez-Salas,
“Port-site metastasis after laparoscopic partial nephrectomy:
case report and literature review,” Journal of Endourology, vol.
21, no. 4, pp. 404–407, 2007.
[5] A. Ran´ e, M. K. Eng, and F. X. Keeley, “Port site metastases,”
Current Opinion in Urology, vol. 18, no. 2, pp. 185–189, 2008.
[6] M.J .C uret,“P ortsitemetastases, ”AmericanJournalofSurgery,
vol. 187, no. 6, pp. 705–712, 2004.
[7] Z. Dobronte, T. Wittman, and G. Karacsony, “Rapid devel-
opment of malignant metastases in the abdominal wall after
laparoscopy,” Endoscopy, vol. 10, no. 2, pp. 127–130, 1978.
[8] S. Micali, A. Celia, P. Bove et al., “Tumor seeding in urological
laparoscopy: an international survey,” Journal of Urology, vol.
171, no. 6 I, pp. 2151–2154, 2004.
[9] A. Tsivian and A. A. Sidi, “Port site metastases in urological
laparoscopic surgery,” Journal of Urology, vol. 169, no. 4, pp.
1213–1218, 2003.
[10] J. Rassweiler, A. Tsivian, A. V. Ravi Kumar et al., “Oncological
safety of laparoscopic surgery for urological malignancy:
experience with more than 1,000 operations,” Journal of
Urology, vol. 169, no. 6, pp. 2072–2075, 2003.
[11] P. Fornara, “Port site metastases: fact or ﬁction?” Urologe A,
vol. 41, no. 2, pp. 113–119, 2002.
[12] Y. W. Novitsky, D. E. M. Litwin, and M. P. Callery, “The
net immunologic advantage of laparoscopic surgery,” Surgical
Endoscopy and Other Interventional Techniques, vol. 18, no. 10,
pp. 1411–1419, 2004.
[13] R. A. Highshaw, F. Vakar-Lopez, E. Jonasch, A. W. Yasko, and
S. F. Matin, “Port-site metastasis: the inﬂuence of biology,”
European Urology, vol. 47, no. 3, pp. 357–360, 2005.
[14] M. W. Wichmann, T. P. H¨ uttl, H. Winter et al., “Immuno-
logical eﬀects of laparoscopic vs open colorectal surgery. A
prospective clinical study,” Archives of Surgery, vol. 140, no. 7,
pp. 692–697, 2005.
[ 1 5 ]M .C .O s t ,B .J .T a n ,a n dB .R .L e e ,“ U r o l o g i c a ll a p a r o s c o p y :
basic physiological considerations and immunological conse-
quences,” Journal of Urology, vol. 174, no. 4 I, pp. 1183–1188,
2005.
[16] P. Sylla, I. Kirman, and R. L. Whelan, “Immunological
advantages of advanced laparoscopy,” Surgical Clinics of North
America, vol. 85, no. 1, pp. 1–18, 2005.
[17] E. Kuhry, J. Jeekel, and H. J. Bonjer, “Eﬀect of laparoscopy on
theimmunesystem,”SeminarsinLaparoscopicSurgery,vol.11,
no. 1, pp. 37–44, 2004.
[18] S.Ikramuddin,J.Lucas,E.C.Ellison,W.J.Schirmer,andW.S.
Melvin, “Detection of aerosolized cells during carbon dioxide
laparoscopy,” Journal of Gastrointestinal Surgery,v o l .2 ,n o .6 ,
pp. 580–584, 1998.
[ 1 9 ]C .J i n g l i ,C .R o n g ,a n dX .R u b a i ,“ I n ﬂ u e n c eo fc o l o r e c t a l
laparoscopic surgery on dissemination and seeding of tumor
cells,” Surgical Endoscopy and Other Interventional Techniques,
vol. 20, no. 11, pp. 1759–1761, 2006.
[20] A. Tsivian, A. Shtabsky, J. Issakov, M. Gutman, A. A. Sidi, and
A. Szold, “The eﬀect of pneumoperitoneum on dissemination
and scar implantation of intra-abdominal tumor cells,” Jour-
nal of Urology, vol. 164, no. 6, pp. 2096–2098, 2000.
[21] J. M. Burns, B. D. Matthews, H. S. Pollinger et al., “Eﬀect
of carbon dioxide pneumoperitoneum and wound closure
technique on port site tumor implantation in a rat model,”
Surgical Endoscopy and Other Interventional Techniques, vol.
19, no. 3, pp. 441–447, 2005.
[22] V. J. Halpin, R. A. Underwood, D. Ye et al., “Pneumoperi-
toneum does not inﬂuence trocar site implantation during
tumor manipulation in a solid tumor model,” Surgical
Endoscopy and Other Interventional Techniques, vol. 19, no. 12,
pp. 1636–1640, 2005.
[23] A. Gupta, D. I. Watson, T. Ellis, and G. G. Jamieson,
“Tumour implantation following laparoscopy using diﬀerent
insuﬄation gases,” ANZ Journal of Surgery,v o l .7 2 ,n o .4 ,p p .
254–257, 2002.
[24] D. Mutter, A. Hajri, V. Tassetti, C. Solis-Caxaj, M. Apra-
hamian, and J. Marescaux, “Increased tumor growth and
spread after laparoscopy vs laparotomy: inﬂuence of tumor
manipulation in a rat model,” Surgical Endoscopy, vol. 13, no.
4, pp. 365–370, 1999.
[25] S. W. Lee, R. L. Whelan, J. C. Southall, and M. Bessler,
“Abdominal wound tumor recurrence after open and
laparoscopic-assisted splenectomy in a murine model,” Dis-
easesoftheColonandRectum,vol.41,no.7,pp.824–831,1998.
[26] S. W. Lee, N. R. Gleason, M. Bessler, and R. L. Whelan, “Port
site tumor recurrence rates in a murine model of laparoscopicAdvances in Urology 5
splenectomy decreased with increased experience,” Surgical
Endoscopy, vol. 14, no. 9, pp. 805–811, 2000.
[27] J.T.Bishoﬀ,“Laparoscopicradicalnephrectomy:morcellateor
leave intact? Deﬁnitely morcellate!,” Reviews in Urology, vol. 4,
no. 1, pp. 34–37, 2002.
[28] I. Varkarakis, K. Rha, F. Hernandez, L. R. Kavoussi, and T.
W. Jarrett, “Laparoscopic specimen extraction: morcellation,”
British Journal of Urology International, Supplement, vol. 95,
no. 2, pp. 27–31, 2005.
[ 2 9 ]M .V .M e n g ,T .R .M i l l e r ,I .C h a ,a n dM .L .S t o l l e r ,“ C y t o l o g y
of morcellated renal specimens: signiﬁcance in diagnosis and
dissemination,” Journal of Urology, vol. 169, no. 1, pp. 45–48,
2003.
[30] A. L. Shalhav, I. Leibovitch, R. Lev, D. M. Hoenig, and J.
Ramon, “Is laparoscopic radical nephrectomy with specimen
morcellation acceptable cancer surgery?” Journal of Endourol-
ogy, vol. 12, no. 3, pp. 255–257, 1998.
[ 3 1 ]S .K i n u g a s a ,E .S m i t h ,P .A .D r e w ,D .I .W a t s o n ,a n dG .
G. Jamieson, “Aspirin and indomethacin for the prevention
of experimental port-site metastases,” Surgical Endoscopy and
Other Interventional Techniques, vol. 18, no. 5, pp. 834–838,
2004.
[32] P. Wittich, A. Mearadji, R. L. Marquet, and H. J. Bonjer,
“Irrigation of port sites: prevention of port site metastases?”
Journal of Laparoendoscopic and Advanced Surgical Techniques
A, vol. 14, no. 3, pp. 125–129, 2004.
[33] W. A. A. Tjalma, “Laparoscopic surgery and port-site metas-
tases: routine measurements to reduce the risk,” European
Journal of Gynaecological Oncology, vol. 24, no. 3-4, p. 236,
2003.
[34] R. Steinert, H. Lippert, and M. A. Reymond, “Tumor cell dis-
semination during laparoscopy: prevention and therapeutic
opportunities,” Digestive Surgery, vol. 19, no. 6, pp. 464–472,
2002.
[35] A. Agostini, S. Mattei, I. Ronda et al., “Prevention of port-
site metastasis after laparoscopy,” Gyn´ ecologie, Obst´ etrique &
Fertilit´ e, vol. 30, pp. 878–881, 2002.
[36] M. Pross, H. Lippert, G. Nestler et al., “Eﬀect of low
molecular weight heparin on intra-abdominal metastasis in
a laparoscopic experimental study,” International Journal of
Colorectal Disease, vol. 19, no. 2, pp. 143–146, 2004.
[37] C. Schneider, A. Jung, M. A. Reymond et al., “Eﬃcacy of
surgical measures in preventing port-site recurrences in a
porcine model,” Surgical Endoscopy, vol. 15, no. 2, pp. 121–
125, 2001.
[ 3 8 ]Y .T .C h e n ,S .S .D .Y a n g ,C .H .H s i e h ,a n dC .C .W a n g ,
“Hand port-site metastasis of renal-cell carcinoma following
hand-assisted laparoscopic radical nephrectomy: case report,”
Journal of Endourology, vol. 17, no. 9, pp. 771–773, 2003.